According to ROC curve analysis, irisin can effectively discriminate between patients and healthy individuals with 62.7 % sensitivity and 91.1 % specificity at a cut-off point of 3.21 μg/ml, suggesting its potential value in breast cancer early detection. Here, FNDC5 is linked to breast carcinoma.